ASPN (Aspen Aerogels) Cyclically Adjusted Revenue per Share: $0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASPN Aspen Aerogels Inc ASPN
67 GF Score
Price $6.25
GF Value $4.87
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Aspen Aerogels Cyclically Adjusted Revenue per Share?

Aspen Aerogels ASPN -9.29% 67 Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2026. GuruFocus rates ASPN with a GF Score™ of 67/100 and a GF Value™ of $4.87 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Aspen Aerogels's adjusted revenue per share for the three months ended in Jun. 2026 was $0.601. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Aspen Aerogels's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Aspen Aerogels was -2.20% per year. The lowest was -5.60% per year. And the median was -3.90% per year.

As of today (2026-08-07), Aspen Aerogels's current stock price is $6.25. Aspen Aerogels's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $0.00. Aspen Aerogels's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aspen Aerogels was 10.61. The lowest was 0.53. And the median was 1.89.


Aspen Aerogels  (NYSE:ASPN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aspen Aerogels was 10.61. The lowest was 0.53. And the median was 1.89.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Aspen Aerogels Cyclically Adjusted Revenue per Share Related Terms


Aspen Aerogels Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Aspen Aerogels's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Aerogels Cyclically Adjusted Revenue per Share Chart

Aspen Aerogels Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 6.38 6.45 5.61 5.36

Aspen Aerogels Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.61 5.55 5.36 5.31 0.00

ASPN vs AIRJ, PPIH, JLHL: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, Aspen Aerogels's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Aerogels Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Aspen Aerogels's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aspen Aerogels's Cyclically Adjusted PS Ratio falls into.


ASPN
67GF Score
Aspen Aerogels Inc ASPN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Aerogels Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aspen Aerogels's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.601/333.9520*333.9520
=0.601

Current CPI (Jun. 2026) = 333.9520.

Aspen Aerogels Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.276 241.428 1.765
201612 1.191 241.432 1.647
201703 0.989 243.801 1.355
201706 1.073 244.955 1.463
201709 1.160 246.819 1.570
201712 1.548 246.524 2.097
201803 0.979 249.554 1.310
201806 0.913 251.989 1.210
201809 1.005 252.439 1.330
201812 1.497 251.233 1.990
201903 1.166 254.202 1.532
201906 1.224 256.143 1.596
201909 1.466 256.759 1.907
201912 1.924 256.974 2.500
202003 1.128 258.115 1.459
202006 0.929 257.797 1.203
202009 0.905 260.280 1.161
202012 0.851 260.474 1.091
202103 1.004 264.877 1.266
202106 1.111 271.696 1.366
202109 0.934 274.310 1.137
202112 0.963 278.802 1.153
202203 1.166 287.504 1.354
202206 1.296 296.311 1.461
202209 0.928 296.808 1.044
202212 1.209 296.797 1.360
202303 0.659 301.836 0.729
202306 0.695 305.109 0.761
202309 0.876 307.789 0.950
202312 1.203 306.746 1.310
202403 1.247 312.332 1.333
202406 1.491 314.175 1.585
202409 1.539 315.301 1.630
202412 1.469 315.605 1.554
202503 0.959 319.799 1.001
202506 0.949 322.561 0.983
202509 0.886 324.800 0.911
202512 0.500 324.054 0.515
202603 0.458 330.213 0.463
202606 0.601 333.952 0.601

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
Aspen Aerogels (ASPN) has a Cyclically Adjusted Revenue per Share of $0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aspen Aerogels and its competitors.
Is Aspen Aerogels' Cyclically Adjusted Revenue per Share too high?
Aspen Aerogels' current Cyclically Adjusted Revenue per Share is $0.00. Overall, Aspen Aerogels has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Aerogels' Cyclically Adjusted Revenue per Share compare to AIRJ and PPIH?
Aspen Aerogels' Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aspen Aerogels and its competitors. Aspen Aerogels's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Aerogels stock overvalued right now?
Based on GuruFocus' analysis, Aspen Aerogels (ASPN) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.87, compared to a current price of $6.25 — trading 28.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.00. Aspen Aerogels' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Aspen Aerogels (ASPN), the current Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Aerogels (ASPN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Aerogels stock appears to be overvalued. The current stock price of $6.25 is trading 28.3% above its estimated GF Value™ of $4.87. GuruFocus considers Aspen Aerogels to be Modestly Overvalued.

Key valuation signals for ASPN:

  • Cyclically Adjusted Revenue per Share: $0.00
  • GF Value™: $4.87 vs. price of $6.25 (28.3% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the ASPN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aspen Aerogels Business Description

Address 30 Forbes Road, Building B, Northborough, MA, USA, 01532
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
67GF Score

Get the complete analysis for ASPN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.25
Price
$4.87
GF Value